147 related articles for article (PubMed ID: 20457964)
1. Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?
Marignier R; Chenevier F; Rogemond V; Sillevis Smitt P; Renoux C; Cavillon G; Androdias G; Vukusic S; Graus F; Honnorat J; Confavreux C
Arch Neurol; 2010 May; 67(5):627-30. PubMed ID: 20457964
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody status, neuroradiological and clinical findings in children with acute cerebellitis.
Quack L; Glatter S; Wegener-Panzer A; Cleaveland R; Bertolini A; Endmayr V; Seidl R; Breu M; Wendel E; Schimmel M; Baumann M; Rauchenzauner M; Pritsch M; Boy N; Muralter T; Kluger G; Makoswski C; Kraus V; Leiz S; Loehr-Nilles C; Kreth JH; Braig S; Schilling S; Kern J; Blank C; Tro Baumann B; Vieth S; Wallot M; Reindl M; Ringl H; Wandinger KP; Leypoldt F; Höftberger R; Rostásy K
Eur J Paediatr Neurol; 2023 Nov; 47():118-130. PubMed ID: 38284996
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic cerebellar and brainstem disorders.
Abbatemarco JR; Vedeler CA; Greenlee JE
Handb Clin Neurol; 2024; 200():173-191. PubMed ID: 38494276
[TBL] [Abstract][Full Text] [Related]
4. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
[TBL] [Abstract][Full Text] [Related]
5. [Blood-brain barrier breakdown and autoimmune cerebellar ataxia].
Shimizu F
Rinsho Shinkeigaku; 2024 Mar; 64(3):148-156. PubMed ID: 38403685
[TBL] [Abstract][Full Text] [Related]
6. Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome.
Thakolwiboon S; Linnoila J; Pittock SJ; Dubey D; Zekeridou A
J Neuroimmunol; 2024 Feb; 387():578293. PubMed ID: 38266443
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against eukaryotic translation elongation factor 1 delta in two patients with autoimmune cerebellar ataxia.
Guo L; Ren H; Fan S; Chao X; Liu M; Guan H; Wang J
Front Immunol; 2023; 14():1289175. PubMed ID: 38332912
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic movement disorders.
McKeon A; Tracy J
Handb Clin Neurol; 2024; 200():211-227. PubMed ID: 38494279
[TBL] [Abstract][Full Text] [Related]
9. Persisting Verbal Memory Encoding and Recall Deficiency after mGluR5 Autoantibody-Mediated Encephalitis.
Hansen N; Rentzsch K; Hirschel S; Wiltfang J; Schott BH; Malchow B; Bartels C
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002497
[TBL] [Abstract][Full Text] [Related]
10. Identification of DAGLA as an autoantibody target in cerebellar ataxia.
Miske R; Scharf M; Borowski K; Specht I; Corty M; Loritz MJ; Rombach F; Laureys G; Rochow N; Radzimski C; Schnitter L; Ratuszny D; Skripuletz T; Wattjes MP; Hahn S; Denno Y; Guerti K; Oyaert M; Benkhadra F; Bien CI; Nitsch S; Wandinger KP; van Pesch V; Probst C; Teegen B; Komorowski L; Sühs KW
J Neurol Neurosurg Psychiatry; 2024 Apr; ():. PubMed ID: 38663995
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease impairs cerebellar growth.
Griffin WS; Head JR; Woodward DJ; Carrol C
Nature; 1978 Sep; 275(5678):315-7. PubMed ID: 692707
[No Abstract] [Full Text] [Related]
12. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
13. Patient with homer-3 antibodies and cerebellitis.
Höftberger R; Sabater L; Ortega A; Dalmau J; Graus F
JAMA Neurol; 2013 Apr; 70(4):506-9. PubMed ID: 23400636
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Lopez-Chiriboga AS; Komorowski L; Kümpfel T; Probst C; Hinson SR; Pittock SJ; McKeon A
Neurology; 2016 Mar; 86(11):1009-13. PubMed ID: 26888994
[TBL] [Abstract][Full Text] [Related]
15. Video NeuroImages: Head titubation in anti-mGluR1 autoantibody-associated cerebellitis.
Pedroso JL; Dutra LA; Espay AJ; Höftberger R; Barsottini OGP
Neurology; 2018 Apr; 90(16):746-747. PubMed ID: 29661893
[No Abstract] [Full Text] [Related]
16. Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma.
Iorio R; Damato V; Mirabella M; Vita MG; Hulsenboom E; Plantone D; Bizzarro A; Del Grande A; Sillevis Smitt PA
J Neuroimmunol; 2013 Oct; 263(1-2):155-8. PubMed ID: 23958353
[TBL] [Abstract][Full Text] [Related]
17. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Höftberger R; Boronat A; Saiz A; Dalmau J; Graus F
PLoS One; 2013; 8(3):e60438. PubMed ID: 23536908
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
Mitoma H; Manto M; Hampe CS
Curr Neuropharmacol; 2019; 17(1):33-58. PubMed ID: 30221603
[TBL] [Abstract][Full Text] [Related]
19. Nonparaneoplastic autoimmune cerebellar ataxias.
Joubert B; Honnorat J
Curr Opin Neurol; 2019 Jun; 32(3):484-492. PubMed ID: 30694927
[TBL] [Abstract][Full Text] [Related]
20. Immune-mediated ataxias.
Joubert B; Rostásy K; Honnorat J
Handb Clin Neurol; 2018; 155():313-332. PubMed ID: 29891069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]